Clinical Trials Directory

Trials / Completed

CompletedNCT03102645

Does Single Dose Imipramine Affect the Opening Pressure of the Urethral and Anal Sphincter?

Effect of Single Dose Imipramine on the Urethral and Anal Sphincter in Healthy Women Measured With Urethral Pressure Reflectometry (UPR) and Anal Acoustic Reflectometry (AAR)

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
16 (actual)
Sponsor
Jonatan Kornholt · Academic / Other
Sex
Female
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

A double-blinded, randomized, crossover study in healthy females with placebo and single dose imipramine 50 mg. Primary objective: Does imipramine increase the tone of the external urethral sphincter? Urethral Opening Pressure (UOP) is measured with Urethral Pressure Reflectometry (UPR). UOP increases correlate with effect in treating stress urinary incontinence. Can imipramine treat stress urinary incontinence? Secondary objective: Does imipramine increase the tone of the anal sphincter? The opening pressure is measured with Anal Acoustic Reflectometry (AAR). The investigators also wish to establish the within-subject standard deviation for AAR to enable power calculations in future studies.

Conditions

Interventions

TypeNameDescription
DRUGPlacebo Oral TabletPlacebo film coated tablet: Lactose monohydrate, potato starch, gelatine, magnesium stearate, talc
DRUGImipramine Hydrochloride 25 MGTwo Imipramin DAK film coated tablets 25 mg each, single dose

Timeline

Start date
2017-05-16
Primary completion
2017-06-16
Completion
2017-06-21
First posted
2017-04-06
Last updated
2021-02-12
Results posted
2021-02-12

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT03102645. Inclusion in this directory is not an endorsement.